SCN may predispose to MDS or AML, as a result of causative variants in ELANE, HAX1, G6PC3, WAS, GATA2, SBDS, CLPB, CSF3R, and the leukemia-associated genes in a majority of patients (44). This evidence concerns the gene G6PC3 and myelodysplastic syndrome.